RENO, Nev.–IpAuctions, Inc. is selling the patents and patent applications developed by Predicant Biosciences, formerly called BioSpect, and certain intellectual property of Perlegen. Predicant Biosciences, a California-based biotechnology company, developed technology and intellectual property to identify complex protein patterns in blood to detect and diagnose disease, methods to relate genotypes to phenotypes, and techniques to […]

SAN DIEGO — Sequenom, Inc. (Nasdaq: SQNM) today announced that Dr. Wolfgang Holzgreve has joined the company’s Clinical Advisory Board. Dr. Holzgreve currently serves as Director and Chairman of the Board of Directors at the University Hospital Freiburg, Germany. “We are very pleased to welcome Wolfgang to our Clinical Advisory Board,” said Dr. Allan Bombard, […]

Runcorn, Cheshire, United Kingdom — Thermo Fisher Scientific (NYSE: TMO) to supply OPTEC, LLC with Cancer Diagnostic Instrumentation as Part of National Oncological Program in Russia. Thermo Fisher Scientific, the world leader in serving science, today announced a distribution partnership with OPTEC LLC, the leading provider of cutting-edge medical, surgical, microscopic and industrial metrology solutions […]

Salt Lake City, UT — Idaho Technology, Inc. (ITI) announced today that clinical trials of the FilmArray Respiratory Panel (RP) have commenced at three US Hospital Laboratories. “We believe that the FilmArray RP holds tremendous potential for hospital clinical laboratories frustrated with the hassle, long turnaround times, and inferior sensitivity and specificity of viral culture, […]

Pioneer in antibody selection unveils powerful technology to use high performance antibodies on genomics platforms BRANFORD, Conn.–Affomix Corporation, a pioneer in high performance antibody technology, announced today a collaboration with City of Hope focused on establishing the clinical utility of “digital proteomics” with next generation sequencers. One of the nation’s top cancer research and treatment […]

SAN DIEGO — Sequenom, Inc. (Nasdaq: SQNM), announced today the entry of a settlement agreement which will resolve the consolidated securities class action lawsuits, In re Sequenom, Inc. Securities Litigation, Master File No: 3:09-cv-00921-LAB-WMC. The defendants have agreed to pay $14 million, which will be funded by insurance proceeds. Additionally the company has agreed to […]

Company to leverage new production site to capture growth in China and expand Point of Care and rapid diagnostics offer for both emerging and developed countries MARCY L’ETOILE, France, Jan. 14 — A world leader in in vitro diagnostics, bioMerieux announced today the acquisition of the rapid test manufacturer, Meikang Biotech, and its large production […]

NEW YORK–Enzo Biochem, Inc. (NYSE: ENZ) announced today that its Enzo Clinical Labs division has become one of the first diagnostic laboratories to make available a rapid and sensitive H1N1 PCR test for the swine flu virus. Enzo Clinical Labs serves physicians throughout the Metropolitan New York area, as well as New Jersey and parts […]

Applications of Newly Added Molecular Detection Technology Include Point-of-Need Testing in Molecular Diagnostics and Applied Testing VENLO, The Netherlands — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced that it has acquired ESE GmbH, a privately held developer and manufacturer of UV and fluorescence optical measurement devices. ESE is based in Stockach, Germany. […]